Effect of exclusive breastfeeding on selected adverse health and nutritional outcomes: a nationally representative

Md Nuruzzaman Khan1, M Mofizul Islam2,3

  • 1Department of Population Sciences, Jatiya Kabi Kazi Nazrul Islam University, Mymensingh, 2220, Bangladesh. sumonrupop@gmail.com.

BMC Public Health
|November 23, 2017
PubMed

Insights

Exclusive breastfeeding (EBF) for six months significantly reduces infant illness and malnutrition. Discontinuing EBF early increases risks of diarrhea, fever, and underweight in infants, highlighting the importance of sustained EBF for child health.

Area of Science:

  • Pediatrics
  • Public Health
  • Nutrition Science

Background:

  • Exclusive breastfeeding (EBF) is recommended for infants' first six months, yet optimal duration remains debated.
  • This study investigates the health and nutritional impacts of discontinuing EBF at 2, 4, and 6 months postpartum.

Purpose of the Study:

  • To analyze the association between early EBF cessation and adverse infant health and nutritional outcomes.
  • To quantify the preventable burden of specific infant illnesses and under-nutrition attributable to suboptimal EBF duration.

Main Methods:

  • Analysis of three waves of Bangladesh Demographic and Health Survey data using multivariate regression.
  • Assessment of infant health outcomes (diarrhea, fever, acute respiratory infection) and nutritional status (stunting, wasting, underweight).
  • Calculation of population attributable fractions to estimate the impact of EBF on these outcomes.

Main Results:

  • Fifty-six percent of infants achieved EBF for the first six months.
  • Lack of EBF was associated with increased odds of diarrhea, fever, and acute respiratory infection (ARI).
  • Early EBF termination (0-2 or 2-4 months) significantly increased the odds of infants being underweight.

Conclusions:

  • Infants not exclusively breastfed for at least six months face higher risks of infectious diseases and under-nutrition.
  • Public health interventions should prioritize and promote EBF for the first six months of life.
Abstract

Related Concept Videos

Anatomy of the Intestines01:23

Anatomy of the Intestines

Although digestion of proteins, carbohydrates, and lipids may begin in the stomach, it is completed in the intestine. The absorption of nutrients, water, and electrolytes from food and drink also occurs in the intestine. The intestines can be divided into two structurally distinct organs—the small and large intestines.
Small Intestines
The small intestine is an ~7 meter-long tube with an inner diameter of just 2.5 cm. Since most nutrients are absorbed here, the inner lining of the...
88.2K
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
334
Study Designs in Epidemiology01:20

Study Designs in Epidemiology

Epidemiological study designs are fundamental tools for investigating the distribution, determinants, and control of health conditions in populations. They help researchers understand the relationships between exposures and outcomes, and they broadly fall into two categories: "observational" and "experimental" studies.
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and...
1.1K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
488
Bioavailability Study Design: Absolute Versus Relative Bioavailability01:27

Bioavailability Study Design: Absolute Versus Relative Bioavailability

Bioavailability is a crucial pharmacokinetic parameter that quantifies the proportion of an administered drug that reaches the systemic circulation and is available for therapeutic action. Regulatory agencies mandate the assessment of bioavailability, typically measured as the area under the drug plasma concentration-versus-time curve (AUC), to ensure the efficacy and safety of pharmaceutical products. These evaluations are categorized as absolute and relative bioavailability studies.Absolute...
402
Bias in Epidemiological Studies01:29

Bias in Epidemiological Studies

Biases can arise at various stages of research, from study design and data collection to analysis and interpretation. Recognizing and addressing these biases is essential to ensure the validity and reliability of epidemiological findings.Broadly speaking, biases in epidemiology fall into three main categories: selection bias, information bias, and confounding. A more detailed description of possible biases is:  
1.4K